gdc
CONQUER Cam: A Spotlight on Your Story
CONQUER CamMultiple MyelomaPatient Stories

CONQUER Cam: A Spotlight on Yelak Biru

Yelak Biru recalls being initially diagnosed with stage 3 multiple myeloma at age 25, and his subsequent relapse. Working with oncology teams, educating himself through support groups, and getting involved in associations as a speaker, Yelak has integrated myeloma into his life by becoming a patient advocate.
Video Library
Yelak Biru
Patient, North Texas Myeloma Support Group Leader; Member, International Myeloma Foundation; Advisory Committee Chair, Global Myeloma Action Network

Share this:

Recommended For You
Patient StoriesBreast CancerCOVID-19 & Cancer
No Pair, I Don’t Care!
By Kiana Wooten
In May 2019, Kiana Wooten went for a routine check-up. Read about how that routine visit turned into a breast cancer diagnosis for the 34-year-old Kiana, who had to be hospitalized during COVID-19.
Patient StoriesSkin Cancer
Climate Change Plays Havoc on Weather Patterns, and on Skin Cancer Rates
By Mark T. Ryan, RN
Mark Ryan, RN, is not worried about the impact of climate change on the weather, but on skin cancer, which he knows first-hand. A decrease in stratospheric ozone requires stringent environmental regulations to prevent cancer, he says.
LymphomaPatient Stories
Despite No Sex, We Were Never So Married
By Susan Keller
After putting off her neck pain for months, Susan Keller found that she had lymphoma, describing how her loving husband helped her change her attitude and persist through it all.
FDA Approvals, News & UpdatesMultiple Myeloma
FDA Approves Abecma, First CAR T-Cell Therapy for Multiple Myeloma
Abecma is the first gene therapy approved by the FDA for patients with multiple myeloma. It uses the patient’s own genetically modified T-cells to fight the cancer.
Last modified: July 19, 2018

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country